Without full knowledge of your medical condition and background and a review of policy conditions and premiums the calculations are little more than a guess intended to capture your attention.

Life settlement is the term given to describe a financial transaction in which a policyholdersells their life insurance policy to a third party – usually a financial institution or regulatedprovider – at a discount to its maturity value. The purchaser pays all remaining premiumsand receives the life insurance benefit when the policy matures. Investors are attracted to lifesettlements because they offer long-term growth potential that is generally not affected byinterest rate movements, volatility in the equity markets, global events or economic downturns.

Start by comparing your health to the health of others your age: Standard – My health is average compared to others my age. Slightly Impaired – I have had very few health issues compared to others my age. Moderately Impaired – I have chronic but manageable, health conditions that require ongoing treatment and care, but they do not have a significant impact on my quality of life relative to my peers. Highly Impaired - I have chronic medical conditions that frequently impact my quality of life. Extremely Impaired – I have major or severe medical conditions that constantly affect my quality of life. Terminal – I have irreversible medical conditions that will significantly reduce life expectancy, such as late-stage cancer.

An investor investing in policies will assume the credit risk associated with policies issued byvarious life insurance companies. The failure or bankruptcy of any such life insurance companycould have a material adverse impact on an investor’s returns. However, the risk of bankruptcyis low and to date, we know of no death benefit that has been unpaid as a result of thebankruptcy or financial difficulties of any U.S. life insurance carrier.

Life insurance policies typically have a contestability clause, which permits the issuing life insurance company to contest its obligation to pay a death benefit based upon any material misrepresentation or omission made by the applicant or the insured on the life insurance application within, generally, the first two (2) years of the policy issue date. Life insurance companies may also contest policies based on a lack of insurable interest, which claim may survive the expiration of the two (2) year contestability period.

Some U.S. life insurance companies have voiced concerns about the life settlement industry generally and the transfer of policies to investors. These life insurance companies may be averse to transferring or honouring a policy by third parties unrelated to the original insured/owner, especially when they may believe the initial premiums for such policies might have been financed, directly or indirectly, by the purchaser. Certain improperly originated policies are sometimes known as stranger-originated life insurance transactions or STOLI.

Former beneficiaries or heirs of the policy may challenge the validity of the sale of the policyand consequently contest, obstruct or delay the payment of the proceeds of a policy followingan insured’s death, based on a variety of factors including a lack of insurable interest, mentalcapacity of the insured, applicable periods of contestability or suicide provisions.

Some insurance policies terminate if the insured lives to the age of 100, or in some cases atage 95. If the insured outlives the policy, an investor owning such a policy may get nothingon that policy as the insurer is relieved of its obligation. Such a policy termination wouldresult in a loss of investment return on the policy.

Once a US policy has passed the non-contestability period (two years) it will pay out even in the event of suicide or euthanasia. However, most policies are not covered in the event of war or terrorism.

A life settlement policy transaction begins with a policy owner obtaining a health assessment, known as a life expectancy analysis (LE) report from an independent, third-party medical underwriter so that the EstimatedMaturity Date (EMD) can be calculated. Based upon health and medical information, anevaluation can be made, and life expectancy determined by that independent medicalunderwriting firm. Each policy is medically underwritten, and a life expectancy reportproduced. Subject to the criteria determined by the appointed provider the other conditions are satisfied, and a policy is purchased by the Escrow Agent, pursuant to a purchase agreement and otherancillary closing documents that transfers the legal ownership and beneficial interest in thepolicy to that Agent.

Estimated maturity dates (EMD) are based on life expectancy (LE) calculations. They provide an estimate of the expected time to the death of the insured.

The value of the policies life settlement market depends, among other things, upon the life expectancy of the insured. Life expectancies are estimates of the expected longevity or mortality of an insured and are inherently uncertain, especially in small sample sizes. There can be no assurance that any life expectancy obtained on an insured for a policy will be predictive of the future longevity or mortality of the insured. The actual maturity date of the policies may therefore be longer than projected, which would negatively impact the time and therefore the return on investment. In addition, improvements in medicine, disease treatment, pharmaceuticals and other medical and health services may enable insurers to live longer. To the extent actuarial assumptions differ from actual results, as to life expectancy or other assumptions made in the pricing or valuing of policies, an investor may over-pay for a policy. In addition, to the extent an investor obtains any policy based on the perceived life expectancy and such perception is inaccurate, distributions from the maturity of that policy may be delayed; in some cases, such delays could be significantly long. Current mortality tables are relied upon in part to forecast future cash flows in determining the prices paid to acquire policies. However, future mortality experiences may not resemble the mortality experiences of the past.

Each policy pays a fixed return to the policy owner or beneficiary when the life insured dies. The calculation of the annual return will be the face value (sum assured payable at death) less the total cost including premiums and fees divided by the total cost and further divided by the number of years before EMD. Simply put, for example, a policy that costs $100k including premiums and fees with an EMD of 9 years whose face value of $190k pays out on EMD an absolute return of 10% per annum. $190k – $100k = 90k, divided by 9 years = $10k per year or 10% per annum absolute return. If the policy matures early the fixed return ($190k, in the example) remains the same but the annual return will increase. If the policy matures late the fixed return remains the same ($190k, in the example) but the annual return will decrease. Policies that mature much earlier than the EMD return a significantly higher payout to the investor. Life Settlement Connect prices policies to be profitable up to 150% of the EMD, even policies that mature well past the EMD may provide an attractive return. However, if the investor chooses to take over payment of premiums and fees and the policy runs beyond twice the EMD (e.g. if the LE report estimated that the insured would die on or before 40 months from EMD but actual maturity is more than 80 months after the EMD) then the original investment is at risk

The policy is valued by discounting the face value by the required annual return percentageto the EMD as detailed in the previous question.

Though the maturity value – the death benefit - will be paid and that amount is protected the investor’s principal is not. If premiums are not paid or need to be paid past EMD then the value of the investment can be eroded.

Not necessarily, in fact if they both have similar EMDs provided by the life expectancy providers there is a strong argument to prefer the younger life where premiums may be lower and increase more slowly (see chart). There is also a likelihood that the 65year old will have lifestyle complications that the 80year old does not suffer.

Clearly the access to a higher level of medical care will be important, it could also be said that with medicine as it is today the wealthy can be kept alive far beyond expectations. It might also be that the lifestyle of the wealthy has historically been less impaired than that of the poorer insured.

Answers to the two preceding questions provide this answer also.

One reason may be that premium income is extremely valuable given the front-end cost of new policies and means that carriers are prepared to take on existing life insurance from another, failing, carrier.

CONNECT has no interest in any policy and acts purely as an automated collector of the information needed to sell the policy through a licensed provider.

The policy owner.

There are many reasons why the insured would want to sell a policy: • The policy may no longer be needed or wanted • Premium payments may have become unaffordable • They could be considering lapse or surrender of the policy • There may have been a change in estate planning needs • The beneficiary for whom the policy was originally purchased is now deceased or no longer has a need for the policy. • The policyholder requires funds to pay for medical expenses or for new or experimental treatments for themselves or someone close to them • The sale of the policy would allow the policyholder to maintain a desired standard of living and live out his/her final years with dignity.

Policy proceeds may be subject to tax. Investors should seek independent professional advice on their individual tax and legal circumstances.